At Sanofi, our passion is to prevent, treat and cure illness and disease through life. We are driven to improve the health of communities and to find new solutions for patients by combining breakthrough science with advanced technology.
Having a voice matters and at Sanofi we believe that shaping what we do within our company is just as important as participating in our industry and community conversations. This is why we're always proud to contribute to important topics and see our experts elected to Boards and working groups.
We have developed clear positions on important policies and topics related to healthcare. Learn more about our positions below.
Jan 31, 2023 • POSITIONMeasuring What MattersJan 27, 2023 • POSITION2023-24 Pre-Budget SubmissionOct 8, 2021 • POSITIONNational Medicines Policy Review SubmissionOct 5, 2021 • ACTION PLANSubmission to Senate manufacturing inquiryMay 26, 2021 • ACTION PLANReconciliation Action Plan 2021-2022Oct 13, 2020 • POSITIONInquiry into approval processes for new drugs and novel medical technologiesOct 26, 2020 • ACTION PLANGender Equity Action Plan 2020-2022Jun 30, 2020 • POSITIONCOVID-19 and Australian foreign affairs, defence and tradeJun 17, 2020 • ACTION PLANAccessibility Inclusion Plan 2020-2021May 28, 2020 • POSITIONResponse to senate select committee on COVID-19Mar 6, 2020 • POSITIONNational Cancer PlanMar 6, 2020 • POSITIONTreasury Laws Amendment (Research and Development Tax Incentive) Bill 2019
Working groups and representation
Sanofi is currently members of the following:
- Medicines Australia Chief Executive Group
- Co-Chair of Medicines Australia Regulatory Affairs Working Group
- Medicines Australia Government Working Group
- Medicines Australia Continuing Education Program Working Group
- Medicines Australia Access to Medicines Working Group for Biosimilars
- Medicines Australia Vaccines Interest Group
- Australian Network on Disability
ACON - AIDS Council of NSW